{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:47:52Z","timestamp":1761763672446},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/ctrv.2001.0230","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:54:50Z","timestamp":1032429290000},"page":"283-288","source":"Crossref","is-referenced-by-count":5,"title":["Chemotherapy in patients with metastatic or relapsed germ-cell tumours"],"prefix":"10.1053","volume":"27","author":[{"given":"O.","family":"Rick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Siegert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ctrv.2001.0230_RF1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199707243370406","article-title":"Testicular germ-cell cancer","volume":"337","author":"Bosl","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/ctrv.2001.0230_RF2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/0003-4819-109-7-540","article-title":"Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide","volume":"109","author":"Loehrer","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1053\/ctrv.2001.0230_RF4","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1200\/JCO.1999.17.11.3450","article-title":"First-line high-dose chemotherapy compared with standard-dose PEB\/VIP chemotherapy in patients with advanced germ cell tumors: a multivariate and matched-pair analysis","volume":"17","author":"Bokemeyer","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1200\/JCO.2001.19.1.81","article-title":"Salvage treatment with paclitaxel, ifosfamide and cisplatin (TIP) plus high-dose carboplatin, etoposide and thiotepa (CET) followed by autologous stem cell rescue in patients with relapsed or refractory germ cell cancer","volume":"19","author":"Rick","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF6","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.1990.8.11.1777","article-title":"Treatment of testicular cancer: a new and improved model","volume":"8","author":"Einhorn","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/JCO.1986.4.3.400","article-title":"Prognostic factors for favorable outcome in disseminated germ cell tumors","volume":"4","author":"Birch","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/A:1008279222625","article-title":"Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB\/ACE chemotherapy","volume":"8","author":"Bower","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JCO.1998.16.2.692","volume":"16","author":"Kaye","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00000421-199704000-00017","article-title":"Experience with bleomycin, etoposide, cisplatin (BEP) an alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II)\/vinblastine, bleomycine (VB (IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors","volume":"20","author":"Culine","year":"1997","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/bjc.1995.254","article-title":"Four cycles of BEP versus an alternating regimen and PVB and PEB in patients with poor prognosis metastatic testicular non-seminoma: A randomized study of the EORTC-Genitourinary Tract Cancer Cooperative Group","volume":"71","author":"de Wit","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1053\/ctrv.2001.0230_RF12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM198706043162302","article-title":"Treatment of disseminated germ cell tumors with cisplatin, bleomycin and either vinblastin or etoposid","volume":"316","author":"Williams","year":"1987","journal-title":"New Engl J Med"},{"key":"10.1053\/ctrv.2001.0230_RF13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000474596","article-title":"Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminmatous germ cell tumours: Preliminary results of a French randomized trial","volume":"23","author":"Chevreau","year":"1993","journal-title":"Eur Urol"},{"key":"10.1053\/ctrv.2001.0230_RF14","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.1997.15.7.2546","article-title":"High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors","volume":"15","author":"Motzer","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF15","first-page":"24","article-title":"The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors: German Testicular Cancer Study Group","volume":"25","author":"Bokemeyer","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF16","first-page":"3403","article-title":"Multivariate analysis of prognostic variables in patients with metastatic testicular cancer","volume":"43","author":"Bosl","year":"1983","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2001.0230_RF17","first-page":"8","volume":"1","year":"1985","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2001.0230_RF18","first-page":"2414","article-title":"Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: Results from an EORTC multiinstitutional phase III study","volume":"47","author":"Stoter","year":"1987","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2001.0230_RF19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/1097-0142(19880801)62:3<564::AID-CNCR2820620321>3.0.CO;2-A","article-title":"Prognostic factors in advanced nonseminomatous testicular cancer","volume":"62","author":"Droz","year":"1988","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2001.0230_RF20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1991.9.5.818","article-title":"Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: A multicentre experience","volume":"9","author":"Aass","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/oxfordjournals.annonc.a010473","article-title":"Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer","volume":"7","author":"Bokemeyer","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF22","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1200\/JCO.2000.18.12.2413","article-title":"Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer","volume":"18","author":"Motzer","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF23","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1200\/JCO.2000.18.6.1173","article-title":"Sequential dose-intensive paclitaxel, ifosfamide, carboplatin and etoposide salvage therapy for germ cell tumor patients","volume":"18","author":"Motzer","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00185676","article-title":"Treatment intensification in disseminated germ-cell tumors","volume":"12","author":"Beyer","year":"1994","journal-title":"World J Urol"},{"key":"10.1053\/ctrv.2001.0230_RF25","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1200\/JCO.1997.15.4.1427","article-title":"Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma","volume":"15","author":"Miller","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF26","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.1998.16.7.2500","article-title":"Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor","volume":"16","author":"Loehrer","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<839::AID-IJC26>3.0.CO;2-A","article-title":"High-dose salvage chemotherapy. Germ-cell tumor treatment results in Germany","volume":"83","author":"Rick","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1053\/ctrv.2001.0230_RF28","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1023\/A:1008328012040","article-title":"A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission","volume":"10","author":"Rodenhuis","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF29","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1200\/JCO.1996.14.10.2638","article-title":"High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic factors","volume":"14","author":"Beyer","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1200\/JCO.1994.12.7.1390","article-title":"Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the Indiana University experience","volume":"12","author":"Saxman","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0230_RF31","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/sj.bjc.6690534","article-title":"Prognostic factors in patients progressing after platinum-based chemotherapy for malignant non- seminomatous germ cell tumours","volume":"80","author":"Fossa","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/ctrv.2001.0230_RF32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1023\/A:1011628900089","article-title":"Amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor","volume":"12","author":"Rick","year":"2001","journal-title":"Ann Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737201902300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737201902300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T18:51:19Z","timestamp":1555008679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737201902300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0305737201902300"],"URL":"https:\/\/doi.org\/10.1053\/ctrv.2001.0230","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}